US office doctors to access to Biosite's CHF (congestive heart failure) test:
This article was originally published in Clinica
Executive Summary
Henry Schein, the Melville, New York-based supplier of healthcare products, has agreed to distribute Biosite's Triage BNP test for congestive heart failure (CHF) to office-based doctors in the US. The rapid, point-of-care diagnostic device is designed to diagnose and assess the severity of CHF and to determine the level of risk of a cardiac incident among patients with acute coronary syndromes. According to the American Heart Association, around 5 million people in the US have CHF with 550,000 new cases discovered each year.